Chemopreventive efficacy of hesperetin (citrus flavonone) against 1,2-dimethylhydrazine-induced rat colon carcinogenesis

Toxicology Mechanisms and Methods

Volumn 22, Issue 5, 2012, Pages 397-408

  Nalini, N ^a   Aranganathan, S ^a   Kabalimurthy, J ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

angiogenesis; DMH; Hesperetin; inflammation

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CYCLINE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; HESPERETIN; PROTEIN BAX; PROTEIN BCL 2; VASCULOTROPIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARGENTAFFIN CELL; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; GENE TARGETING; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SILVER STAINING; TREATMENT DURATION;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; HESPERIDIN; MALE; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

CITRUS; RATTUS; RATTUS NORVEGICUS;

EID: 84860856963     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.673092     Document Type: Article

References (45)

1. Adams JM, Cory S. 2001. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61-66. (Pubitemid 32124712)
2. Aranganathan S, Panneer Selvam J, Nalini N. 2009. Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis. Invest New Drugs 27:203-213.
3. Bobek P, Galbavy S. 2001. Influence of inulin on dimethylhydrazine induced carcinogenesis and antioxidant enzymatic system in rat. Biologia (Bratisl) 56:287-291.
4. Boland CR, Luciani MG, Gasche C, Goel A. 2005. Infection, inflammation, and gastrointestinal cancer. Gut 54:1321-1331. (Pubitemid 41192496)
5. Cai Y, Luo Q, Sun M, Corke H. 2004. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 74:2157-2184. (Pubitemid 38210440)
6. Castellone MD, Teramoto H, Gutkind JS. 2006. Cyclooxygenase-2 and colorectal cancer chemoprevention: The β-catenin connection. Cancer Res 66:11085-11088. (Pubitemid 46009929)
7. Choi EJ, Kim GD, Chee KM, Kim GH. 2006. Effects of hesperetin on vessel structure formation in mouse embryonic stem (mES) cells. Nutrition 22:947-951. (Pubitemid 44234009)
8. Choi EM, Kim YH. 2008. Hesperetin attenuates the highly reducing sugar-triggered inhibition of osteoblast differentiation. Cell Biol Toxicol 24:225-231. (Pubitemid 351579709)
9. Choi GS, Lee S, Jeong TS, Lee MK, Lee JS, Jung UJ, Kim HJ, Park YB, Bok SH, Choi MS. 2004. Evaluation of hesperetin 7-O-lauryl ether as lipid-lowering agent in high-cholesterol-fed rats. Bioorg Med Chem 12:3599-3605. (Pubitemid 38746862)
10. Crew TE, Elder DJ, Paraskeva C. 2000. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: Regulation of COX-2 by butyrate. Carcinogenesis 21:69-77. (Pubitemid 30064146)
11. Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, Kofler R, Kroemer G. 1997. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 57: 62-67. (Pubitemid 27020331)
12. DuBois RN, Radhika A, Reddy BS, Entingh AJ. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110:1259-1262. (Pubitemid 26113767)
13. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. 1994. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188. (Pubitemid 24294584)
14. Goel A, Arnold CN, Boland CR. 2001. Multistep progression of colorectal cancer in the setting of microsatellite instability: New details and novel insights. Gastroenterology 121:1497-1502.
15. Halin C, Niesner U, Villani ME, Zardi L, Neri D. 2002. Tumor-targeting properties of antibody-vascular endothelial growth factor fusion proteins. Int J Cancer 102:109-116. (Pubitemid 35168022)
16. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R. 1990. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285-294.
17. Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: Chemistry, metabolism and structure-activity relationships. J Nutr Biochem 13:572-584. (Pubitemid 35246546)
18. Huls G, Koornstra JJ, Kleibeuker JH. 2003. Non-steroidal antiinflammatory drugs and molecular carcinogenesis of colorectal carcinomas. Lancet 362:230-232. (Pubitemid 36859943)
19. Jackson PE, O'Connor PJ, Cooper DP, Margison GP, Povey AC. 2003. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis 24: 527-533. (Pubitemid 36432649)
20. Jänne PA, Mayer RJ. 2000. Chemoprevention of colorectal cancer. N Engl J Med 342:1960-1968. (Pubitemid 30419092)
21. Johnson GC, Miller MA, Ramos-Vara JA. 1995. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa. J Vet Diagn Invest 7:127-136.
22. Kim JY, Jung KJ, Choi JS, Chung HY. 2004. Hesperetin: A potent antioxidant against peroxynitrite. Free Radic Res 38:761-769. (Pubitemid 38812094)
23. Kim JY, Jung KJ, Choi JS, Chung HY. 2006. Modulation of the agerelated nuclear factor-B (NF-B) pathway by hesperetin. Aging Cell 5:401-411. (Pubitemid 44322536)
24. Kim YI, Mason JB. 1996. Nutrition chemoprevention of gastrointestinal cancers: A critical review. Nutr Rev 54:259-279. (Pubitemid 27075897)
25. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, Hakulinen T, Aromaa A. 2002. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76:560-568. (Pubitemid 34920833)
26. Kohno H, Yamaguch K, Taima M, Tanaka T. 2002. Prevention of colonic aberrant crypt foci by dietary feeding of chalcone and 2-hydroxy chalocone in male F344 rats. J Toxicol Pathol 15:137-143.
27. Laemmeli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
28. Lee NK, Choi SH, Park SH, Park EK, Kim DH. 2004. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology 71:174-180.
29. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. 2001. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat Immunol 2:612-619. (Pubitemid 32677628)
30. Li M, Ye C, Feng C, Riedel F, Liu X, Zeng Q, Grandis JR. 2002. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy. Clin Cancer Res 8:3570-3578. (Pubitemid 35340735)
31. Lund EL, Thorsen C, Pedersen MW, Junker N, Kristjansen PE. 2000. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro. Clin Cancer Res 6:4287-4291.
32. Mattern J, Koomägi R, Volm M. 1997. Coexpression of VEGF and bFGF in human epidermoid lung carcinoma is associated with increased vessel density. Anticancer Res 17:2249-2252. (Pubitemid 27320977)
33. Murray PG, Boldy DA, Crocker J, Ayres JG. 1989. Sequential demonstration of antigens and AgNORs in frozen and paraffin sections. J Pathol 159:169-172. (Pubitemid 19257235)
34. Park HJ, Kim MJ, Ha E, Chung JH. 2008. Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNUC4. Phytomedicine 15:147-151. (Pubitemid 350297903)
35. Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jäger R, Weiher H, Furth PA. 1999. Gain of Bcl-2 is more potent than Bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res 59:2541-2545. (Pubitemid 29269094)
36. Singh RP, Banerjee S, Kumar PV, Raveesha KA, Rao AR. 2006. Tinospora cordifolia induces enzymes of carcinogen/drug metabolism and antioxidant system, and inhibits lipid peroxidation in mice. Phytomedicine 13:74-84. (Pubitemid 41797594)
37. Shibata MA, Ito Y, Morimoto J, Otsuki Y. 2004. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinomamodel: a p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis 25:1887-1898. (Pubitemid 39405908)
38. Shrikhande SV, Saoji RR, Barreto SG, Kakade AC, Waterford SD, Ahire SB, Goliwale FM, Shukla PJ. 2007. Outcomes of resection for rectal cancer in India: The impact of the double stapling technique. World J Surg Oncol 5:35.
39. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. 2002. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting thecytochrome c-dependent apoptotic pathway in human colon cancer cells. Cancer Res 62:6323-6328. (Pubitemid 35244488)
40. Takahashi M, Wakabayashi K. 2004. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95:475-480. (Pubitemid 38832695)
41. Takashashi T, Masaki B, Hoyoku N, Toru O. 2006. Cyclooxygenase-2 play a suppressive role for induction of apoptosis in isoliquiritigenintreated mouse colon cancer cells. Cancer Lett 231:319-325.
42. Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. 1998. Cycloxygenase regulates angiogenesis induced by colon cancer cells. Cell.
43. Willett WC, Stampfer MJ, Colditz GA, Rosner BA, Speizer FE. 1990. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323:1664-1672.
44. Yu HP, Xu SQ, Liu L, Shi LY, Cai XK, Lu WH, Lu B, Su YH, Li YY. 2003. Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus. Cancer Lett 198:193-201. (Pubitemid 37297792)
45. Zang XQ. 1996. Progress of study on suppresser, EGFR and CNA in colorectal cancer. Xin Xiaohuabingxue Zazhi; 4: 327-328.